State Of Wyoming Albireo Pharma, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$18.54 - $37.29 $129 - $261	-7 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$23.94 - $33.74 $359 - $506	-15 Reduced 68.18%	7 $0
Q4 2021 Feb 11, 2022	SELL	$21.19 - $31.29 $42 - $62	-2 Reduced 8.33%	22 $1,000
Q3 2021 Feb 11, 2022	SELL	$27.36 - $35.98 $300 - $395	-11 Reduced 31.43%	24 $1,000
Q2 2021 Feb 11, 2022	BUY	$28.9 - $36.87 $1,011 - $1,290	35 New	35 $1,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.